Marianne Stanford

Title: The Innovative Contributions of Marianne Stanford

Introduction

Marianne Stanford is a prominent inventor based in Ottawa, Canada. She has made significant strides in the field of therapeutic treatments, particularly through her innovative research involving the Myxoma virus. Her work has the potential to impact the treatment of various diseases, including cancer.

Latest Patents

Marianne Stanford holds a patent for the "Use of a combination of Myxoma virus and rapamycin for therapeutic treatment." This invention relates to the therapeutic use of a combination of Myxoma virus, which, when used alongside rapamycin, enhances the virus's ability to selectively infect cells with a deficient innate anti-viral response. This combination can be particularly effective in treating diseases characterized by such cells, including cancer. The invention also includes the therapeutic use of Myxoma virus that does not express functional M135R.

Career Highlights

Stanford's career is marked by her dedication to advancing medical research and her commitment to finding innovative solutions to complex health issues. Her work at the University of Western Ontario has positioned her as a leading figure in her field.

Collaborations

Throughout her career, Marianne has collaborated with notable researchers, including Grant McFadden and John Barrett. These partnerships have further enriched her research and contributed to the advancement of therapeutic treatments.

Conclusion

Marianne Stanford's contributions to the field of therapeutic treatments through her innovative use of the Myxoma virus and rapamycin exemplify her commitment to medical research. Her work not only highlights her ingenuity as an inventor but also underscores the potential for significant advancements in cancer treatment.